Usha Sen

Role: Senior Officer at Indoco Remedies Ltd
Location: Navi Mumbai, MH, IN
LinkedIn followers: 500 followers

Manufacturing & ProductionView LinkedIn profile

About Usha Sen

Indoco Remedies Ltd. benefits from a Senior Officer specializing in regulatory affairs with a Master of Pharmacy degree from Biju Patnaik University of Technology, Rourkela. Proficiency in dossier preparation strengthens the company\'s compliance efforts and supports its regulatory strategies. Previous experience as Senior Research Associate at V-Ensure Pharma Technologies refined skills in drug regulatory affairs and presentation. A strong foundation in pharmacy, coupled with interpersonal and presentation skills, fosters effective communication and collaboration within the organization.

Experience

Senior Officer
Indoco Remedies Ltd
Nov 2024 — Present

Education

Biju Patnaik University of Technology, Rourkela
Master of pharmacy- M.pharm, Pharmacy
2019 — 2021
Biju Patnaik University of Technology, Rourkela
Bachelor of Pharmacy - BPharm, Pharmacy
2015 — 2019

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@indoco.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Indoco Remedies Ltd

Pharmaceutical Manufacturing · 5.2K employees · Founded 1947 · Mumbai, Maharashtra, India

Indoco is a fully integrated, research-oriented pharmaceutical company with a strong global presence. The Company’s turnover is US$ 175 million with a human capital of employees, including over 300 skilled scientists and Field. Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. It generates more than 109 million prescriptions annually from over doctors belonging to various specialties. The Company’s R&D team develops non-infringing processes for APIs, formulations and various dosage forms like Immediate Release Tablets, Capsules, Multi-Unit Pellet Systems (MUPS), PDDS, ER Tablets and nano suspensions, as well as a range of injectable solutions, suspensions and depot based long-acting injectables. Indoco has 11 domestic marketing divisions with a strong brand portfolio in various therapeutic segments, including Stomatologicals, Gastro-Intestinal, Respiratory, Anti-Infectives, Vitamins/Minerals/Nutrients, Cold & Cough, Ophthalmics, Antifungal, Antidiabetic & Cardiovascular, Urology, and several others. Top Indoco brands include, Cyclopam, Febrex Plus, ATM, Rexidin M, Karvol Plus, Oxipod, Cital, Sensodent-K, Cital-Uti, Dropizin, Homide, Otorex, Dentogel, Oxipod CV, Turbocort, Febrex, Cloben G, Tuspel LS, Noxa, MCBM 69 etc. Indoco exports a variety of products to regulated and emerging markets, including the USA and EU. The Company has tie-ups with large generic companies and works in close coordination with its customers to leverage core competencies. Indoco’s branded formulations are promoted and distributed across India and in Emerging Markets of South East Asia, Africa, Latin America and CIS. IAS division is USFDA approved and based at Navi Mumbai. It serves customers for their analytical research needs, utilizing state-of-utilizing state-of-the-art instruments and infrastructure.

indoco.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.